Bone Mass Reduction Related to Antipsychotic Use

All Approvals Safety alerts Label changes Trial results Research Guidance Withdrawals

CLINICAL_TRIALS trial_result · 2017-12-26
Clinical Trial Update: Calcium and Vitamin D to Optimize Bone Mass in Boys With Risperidone-induced Hyperprolactinemia [Phase 3]
Phase 3 trial investigating calcium and vitamin D to optimize bone mass in boys with risperidone-induced hyperprolactinemia has completed wi…